Dangers of Anemia Drugs Aranesp, Epogen, and Procrit
Aranesp, Epogen, and Procrit are in a class of drugs called erythropoiesis-stimulating agents (ESAs). These drugs are mostly used to treat anemia in patients with chronic kidney failure and in patients with cancer whose anemia is caused by chemotherapy. But Chicago personal injury attorneys are trying to get the word out about recent studies that prove a high risk of serious and life-threatening side effects and an increasing number of deaths in patients treated with these drugs.
“Federal regulators have announced new warnings for anemia drugs following evidence that they can cause blood clots, worsen cancer, and increase the risk of death in some patients,” says our Illinois personal injury lawyer. FDA officials say Aranesp, Epogen, and Procrit must now carry “black-box” warnings (which are the most serious kind) on their labels to warn about consumers about the newly identified risks. These risks include: “Increased Mortality, Serious Cardiovascular and Thromboembolic Events”. The agency is currently re-evaluating the safe use of this drug class.
Anemia drugs such as these are the fifth-leading class of prescription pharmaceuticals sold in the US. Even though they are extremely expensive and only available by injection, they are overtly advertised directly to consumers. Some Illinois personal injury lawyers say these advertisements have contributed to over-prescribing by doctors, for uses which are often not FDA-approved.
If you or someone you love were prescribed Aranesp, Epogen or Procrit, you should contact a Chicago personal injury attorney immediately.
Popularity: 33% [?]